The third quarter of 2025 delivered robust performance across orthopedics, with total revenues climbing 9.7% year-over-year to reach $9.96 billion. Growth extended across nearly all major segments, driven by steady procedure demand and accelerating adoption of advanced technologies.
Segment-by-Segment Performance
Trauma rose 10.8%, reinforced by its essential nature and consistent patient volumes.
Spine advanced 9.5%, supported by broad adoption of procedural innovations and continued demand across hospital and ASC settings.
Enabling Technology posted one of the quarter’s strongest increases at +16.5%, reflecting rapid expansion of robotics, navigation, and digital integration tools.
Large Joint Reconstruction also saw steady movement, with leadership from Stryker’s Mako system achieving its highest quarterly placement levels to date.
Company-level activity further validated the sector’s strength. ATEC delivered 30%+ revenue growth, while Zimmer Biomet reported a notable rebound in U.S. performance. Treace Medical Concepts, however, signaled pockets of softness in elective procedure volumes.
First Nine Months of 2025 View
Momentum remains consistent through the first three quarters of the year, fueled by growth in trauma, spine, and enabling technologies—areas now shaping investment decisions and technology adoption across practices.
The Takeaway
Q3 2025 reflects an orthopedic market accelerating through both core procedural segments and advanced technology categories. With robotics and navigation expanding rapidly, providers face new opportunities, and complexities, in revenue capture and coding accuracy.
Cosentus continues monitoring how these trends influence surgical workflows, reimbursement patterns, and long-term planning for orthopedic groups across hospital and ASC environments.
